The effects of Maras powder use on patients with migraine

It is accepted that smoking often triggers migraine. However, studies evaluating the relationship between the use of smokeless tobacco and migraine are limited, and there is no clear consensus on the subject. In this study, it was aimed to evaluate the relationship between migraine and Maras powder,...

Full description

Saved in:
Bibliographic Details
Published in:Neuropsychiatric disease and treatment 2018-01, Vol.14, p.1143-1148
Main Authors: İnanç, Yılmaz, Orhan, Fatma Özlem, İnanç, Yusuf
Format: Article
Language:English
Subjects:
Addictions
Analysis
Anxiety
Chewing tobacco
Cigarette
Cigarettes
Education
Females
Headache
Headaches
Health aspects
Maras powder
Migraine
Nervous system agents
Neurology
Nicotine
Original Research
Pain
Patients
Powders (Particulate matter)
smokeless tobacco
Smoking
Systematic review
Tobacco
Turkey
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:It is accepted that smoking often triggers migraine. However, studies evaluating the relationship between the use of smokeless tobacco and migraine are limited, and there is no clear consensus on the subject. In this study, it was aimed to evaluate the relationship between migraine and Maras powder, which is the most common smokeless tobacco in Turkey. The study included a total of 600 subjects, consisting of 300 patients (aged >18 years) diagnosed with a migraine according to the International Headache Society (IHS-ICHD-3 Beta) criteria after presenting at Sütçü Imam University Medical Faculty Neurology Policlinic with the complaint of headache between July 2016 and December 2016 and a control group of 300 individuals with similar features of age, gender, and educational level. A questionnaire was administered to each patient to record the status of smoking or using Maras powder. In the migraine patient group, 16.4% smoked and 9.7% used Maras powder. In the control group, the rate of smoking was 8.5% and the rate of Maras powder use was 11.86%. In males diagnosed with a migraine, the use of Maras powder was found to be at a higher rate than smoking (
ISSN:1176-6328
1178-2021
1178-2021
DOI:10.2147/NDT.S164818